Arcus Biosciences, Inc. RCUS
- quemliclustat — Pancreatic Cancer Phase 3
CD73 (3 companies · 3 programs)
Companies with an active program directed at CD73.
Corvus Pharmaceuticals, Inc. CRVS
- mupadolimab
NovaBridge Biosciences NBP
- uliledlimab — Non-Small Cell Lung Cancer Phase 2